Rimon

Entries tagged “disclosure requirements”

Supreme Court Rejects “Statistical Significance” as Threshold for Required Securities Disclosure

insights April 6, 2011

In Matrixx Initiatives et al. v. Siracusano et al, the unanimous Court held that a pharmaceutical company may be liable for securities fraud by failing to disclose a statistically insignificant number of adverse reactions to a cold medication.   The Supreme Court issued a decision on March 22, 2011 that may help securities class action plaintiffs…

Continue Reading…